{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:55:10Z","timestamp":1791654910014,"version":"4.3.4"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MIUR (Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca)"},{"name":"Progetto PRIN","award":["2010H834LS_005"],"award-info":[{"award-number":["2010H834LS_005"]}]},{"name":"Progetto PRIN","award":["20109PLMH2"],"award-info":[{"award-number":["20109PLMH2"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.pupt.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T00:12:57Z","timestamp":1437178377000},"page":"8-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier"],"prefix":"10.1016","volume":"34","author":[{"given":"Sante","family":"Di Gioia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalucia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Belgiovine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela Fabiola","family":"Craparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennara","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Conese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2015.07.003_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425240902927841","article-title":"Targeted gene delivery to the lung","volume":"6","author":"Aneja","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.pupt.2015.07.003_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2008.09.010","article-title":"Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy","volume":"61","author":"Griesenbach","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10731199.2011.592494","article-title":"Advances in pulmonary delivery of nanoparticles","volume":"40","author":"Kaur","year":"2012","journal-title":"Artif. Cells Blood Substit. Immobil. Biotechnol."},{"key":"10.1016\/j.pupt.2015.07.003_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2009.10.010","article-title":"Vectors for pulmonary gene therapy","volume":"390","author":"Geiger","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2015.07.003_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v14.i4.20","article-title":"Pulmonary drug delivery: physiologic and mechanistic aspects","volume":"14","author":"Yu","year":"1997","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.pupt.2015.07.003_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0378-4274(98)00326-9","article-title":"Immunobiology of dendritic cells in the respiratory tract: steady-state and inflammatory sentinels?","volume":"102\u2013103","author":"McWilliam","year":"1998","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.pupt.2015.07.003_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1513\/pats.2306016","article-title":"From mucins to mucus: toward a more coherent understanding of this essential barrier","volume":"1","author":"Thornton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.pupt.2015.07.003_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.08-0412","article-title":"Mucins, mucus, and sputum","volume":"135","author":"Voynow","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2015.07.003_bib10","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pupt.2015.07.003_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1085\/jgp.118.2.223","article-title":"The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition","volume":"118","author":"Tarran","year":"2001","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.pupt.2015.07.003_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/adc.51.1.28","article-title":"Mucociliary transport in trachea of patients with cystic fibrosis","volume":"51","author":"Yeates","year":"1976","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.pupt.2015.07.003_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2008.09.011","article-title":"Extracellular barriers in respiratory gene therapy","volume":"61","author":"Sanders","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib15","first-page":"919","article-title":"Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease","volume":"148","author":"Sheils","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pupt.2015.07.003_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","article-title":"The lungs as a portal of entry for systemic drug delivery","volume":"1","author":"Patton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.pupt.2015.07.003_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1970.00310090107013","article-title":"Free cells in the lungs. Some aspects of their role, quantitation, and regulation","volume":"126","author":"Brain","year":"1970","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/jamp.2009.0797","article-title":"Update on macrophage clearance of inhaled micro- and nanoparticles","volume":"23","author":"Geiser","year":"2010","journal-title":"J.\u00a0Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.pupt.2015.07.003_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4155\/tde.12.133","article-title":"\u2018Smart\u2019 non-viral delivery systems for targeted delivery of RNAi to the lungs","volume":"4","author":"Ramsey","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.pupt.2015.07.003_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ar200110p","article-title":"Nonviral pulmonary delivery of siRNA","volume":"45","author":"Merkel","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.pupt.2015.07.003_bib21","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1208\/aapsj0901002","article-title":"Vectors for airway gene delivery","volume":"9","author":"Davis","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.pupt.2015.07.003_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/104303401750148667","article-title":"A\u00a0clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis","volume":"12","author":"Ruiz","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00861-4","article-title":"Gene delivery with synthetic (non viral) carriers","volume":"229","author":"Brown","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2015.07.003_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1521-2254(200003\/04)2:2<128::AID-JGM95>3.0.CO;2-W","article-title":"Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse","volume":"2","author":"Zou","year":"2000","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/hum.2015.027","article-title":"Cystic fibrosis gene therapy in the UK and elsewhere","volume":"26","author":"Griesenbach","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/mthe.1999.0021","article-title":"Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization","volume":"1","author":"Densmore","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jgm.1007","article-title":"Identification of transfected cell types following non-viral gene transfer to the murine lung","volume":"9","author":"Davies","year":"2007","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib28","doi-asserted-by":"crossref","first-page":"34379","DOI":"10.1074\/jbc.M105250200","article-title":"Biological properties of poly-L-lysine-DNA complexes generated by cooperative binding of the polycation","volume":"276","author":"Liu","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pupt.2015.07.003_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-3659(02)00131-1","article-title":"Poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers","volume":"82","author":"Jeong","year":"2002","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2004.11.011","article-title":"Long-circulating DNA-complexed biodegradable multiblock copolymers for gene delivery: degradation profiles and evidence of dysopsonization","volume":"103","author":"Bikram","year":"2005","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jgm.419","article-title":"IONP-PLL: a novel non-viral vector for efficient gene delivery","volume":"5","author":"Xiang","year":"2003","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib32","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1158\/1078-0432.CCR-07-0395","article-title":"p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment","volume":"13","author":"Zou","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pupt.2015.07.003_bib33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/sj.gt.3301492","article-title":"Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in\u00a0vitro and after lung administration in\u00a0vivo","volume":"8","author":"Koping-Hoggard","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nano.2011.06.022","article-title":"Linear polyethylenimine-graft-chitosan copolymers as efficient DNA\/siRNA delivery vectors in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Tripathi","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pupt.2015.07.003_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2007.10.013","article-title":"Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in\u00a0vitro","volume":"125","author":"Germershaus","year":"2008","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2006.06.029","article-title":"Targeted gene delivery with trisaccharide-substituted chitosan oligomers in\u00a0vitro and after lung administration in\u00a0vivo","volume":"115","author":"Issa","year":"2006","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/21691401.2013.832685","article-title":"Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells","volume":"42","author":"Malakooty Poor","year":"2014","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.pupt.2015.07.003_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jps.10285","article-title":"Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process","volume":"92","author":"Okamoto","year":"2003","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.pupt.2015.07.003_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2010.02.018","article-title":"Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation","volume":"144","author":"Mohri","year":"2010","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/bbrc.1999.1458","article-title":"Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in\u00a0vitro","volume":"264","author":"Kukowska-Latallo","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pupt.2015.07.003_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.addr.2007.03.010","article-title":"Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity","volume":"59","author":"Akhtar","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1091581809335177","article-title":"Induction of human alveolar epithelial cell growth factor receptors by dendrimeric nanostructures","volume":"28","author":"Omidi","year":"2009","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.pupt.2015.07.003_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jmcb\/mjp002","article-title":"PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway","volume":"1","author":"Li","year":"2009","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.pupt.2015.07.003_bib44","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.biomaterials.2005.11.011","article-title":"Uronic acids functionalized polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriers","volume":"27","author":"Weiss","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.pupt.2015.07.003_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.pupt.2015.07.003_bib46","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.biomaterials.2007.04.011","article-title":"Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells","volume":"28","author":"Elfinger","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.pupt.2015.07.003_bib47","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.gt.3302299","article-title":"Defining strategies to extend duration of gene expression from targeted compacted DNA vectors","volume":"11","author":"Ziady","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2009.01.012","article-title":"Targeting of the beta(2)-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in\u00a0vitro and lungs in\u00a0vivo","volume":"135","author":"Elfinger","year":"2009","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/mthe.2002.0556","article-title":"Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in\u00a0vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor","volume":"5","author":"Ziady","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2012.06.005","article-title":"An inhalable beta(2)-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung","volume":"162","author":"Luo","year":"2012","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib51","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1021\/bm900707j","article-title":"Self-assembly of ternary insulin-polyethylenimine (PEI)-DNA nanoparticles for enhanced gene delivery and expression in alveolar epithelial cells","volume":"10","author":"Elfinger","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.pupt.2015.07.003_bib52","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.biomaterials.2009.12.035","article-title":"Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues","volume":"31","author":"Geiger","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.pupt.2015.07.003_bib53","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s11095-012-0682-z","article-title":"Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung","volume":"29","author":"Hasenpusch","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pupt.2015.07.003_bib54","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jgm.1082","article-title":"Targeting of the glucocorticoid hormone receptor with plasmid DNA comprising glucocorticoid response elements improves nonviral gene transfer efficiency in the lungs of mice","volume":"9","author":"Dames","year":"2007","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006562","article-title":"Nonviral gene delivery: techniques and implications for molecular medicine","volume":"5","author":"Parker","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib56","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.94.5.1651","article-title":"Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in\u00a0vitro and in\u00a0vivo","volume":"94","author":"Oudrhiri","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pupt.2015.07.003_bib57","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.gt.3300482","article-title":"In\u00a0vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes","volume":"4","author":"Li","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.1999.0009","article-title":"Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis","volume":"1","author":"Noone","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/10611860009102216","article-title":"Gene delivery and expression in human retinal pigment epithelial cells: effects of synthetic carriers, serum, extracellular matrix and viral promoters","volume":"7","author":"Urtti","year":"2000","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.pupt.2015.07.003_bib60","first-page":"455","article-title":"Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk\/ganciclovir-mediated cytotoxicity","volume":"10","author":"Konopka","year":"2005","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.pupt.2015.07.003_bib61","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0014-4827(86)90056-X","article-title":"Construction of transferrin-coated liposomes for in\u00a0vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits","volume":"164","author":"Stavridis","year":"1986","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.pupt.2015.07.003_bib62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(97)00083-5","article-title":"Ligand-targeted liposomes","volume":"29","author":"Willis","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2011.10.033","article-title":"A\u00a0new liposome-based gene delivery system targeting lung epithelial cells using endothelin antagonist","volume":"160","author":"Allon","year":"2012","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib64","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/mt.2008.38","article-title":"A\u00a0receptor-targeted nanocomplex vector system optimized for respiratory gene transfer","volume":"16","author":"Tagalakis","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib65","first-page":"19","article-title":"Inflammatory mediators in cystic fibrosis lung disease","volume":"23","author":"Berger","year":"2002","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.pupt.2015.07.003_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0925-4439(00)00084-3","article-title":"Inhibitory effects of tumor necrosis factor-alpha on cationic lipid-mediated gene delivery to airway cells in\u00a0vitro","volume":"1535","author":"Baatz","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pupt.2015.07.003_bib67","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/jgm.789","article-title":"Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells","volume":"7","author":"Bastonero","year":"2005","journal-title":"J.\u00a0Gene Med."},{"issue":"Pt 10","key":"10.1016\/j.pupt.2015.07.003_bib68","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1099\/0022-1317-74-10-2215","article-title":"Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection","volume":"74","author":"Pavic","year":"1993","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.pupt.2015.07.003_bib69","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1183\/09031936.00044008","article-title":"Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10","volume":"32","author":"Alfaro-Moreno","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2015.07.003_bib70","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejpb.2010.10.014","article-title":"An in\u00a0vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier","volume":"77","author":"Lehmann","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.pupt.2015.07.003_bib71","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1098\/rsif.2009.0288.focus","article-title":"An impaired alveolar-capillary barrier in\u00a0vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction","volume":"7","author":"Hermanns","year":"2010","journal-title":"J.\u00a0R. Soc. Interface"},{"key":"10.1016\/j.pupt.2015.07.003_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jgm.291","article-title":"Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins","volume":"5","author":"Rosenecker","year":"2003","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1183\/09031936.93.05020247","article-title":"Human respiratory mucins","volume":"5","author":"Lamblin","year":"1992","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2015.07.003_bib74","first-page":"40","article-title":"Mucous glycoproteins: a gel of a problem","volume":"20","author":"Carlstedt","year":"1985","journal-title":"Essays Biochem."},{"key":"10.1016\/j.pupt.2015.07.003_bib75","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.ph.57.030195.003223","article-title":"Mucin biophysics","volume":"57","author":"Bansil","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.pupt.2015.07.003_bib76","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1165\/rcmb.2003-0345OC","article-title":"MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions","volume":"31","author":"Henke","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pupt.2015.07.003_bib77","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1164\/ajrccm.164.3.2011041","article-title":"Structural alterations of gene complexes by cystic fibrosis sputum","volume":"164","author":"Sanders","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib78","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.09-0081","article-title":"Induced sputum concentrations of mucin in patients with asthma and chronic cough","volume":"137","author":"Jinnai","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2015.07.003_bib79","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/07853890600585795","article-title":"Treatment of airway mucus hypersecretion","volume":"38","author":"Rogers","year":"2006","journal-title":"Ann. Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1196\/annals.1415.006","article-title":"The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4","volume":"1112","author":"Kater","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pupt.2015.07.003_bib81","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.pupt.2015.07.003_bib82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0005-2736(98)00199-0","article-title":"Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies","volume":"1415","author":"Ruponen","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pupt.2015.07.003_bib83","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/jgm.799","article-title":"Serum albumin enhances polyethylenimine-mediated gene delivery to human respiratory epithelial cells","volume":"7","author":"Carrabino","year":"2005","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.gt.3300556","article-title":"The effect of mucolytic agents on gene transfer across a CF sputum barrier in\u00a0vitro","volume":"5","author":"Stern","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.09.036","article-title":"Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI","volume":"109","author":"Kleemann","year":"2005","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib86","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1023\/A:1012248721523","article-title":"Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density","volume":"18","author":"Mosqueira","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pupt.2015.07.003_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-004-9003-5","article-title":"Polyethylene glycol-conjugated copolymers for plasmid DNA delivery","volume":"22","author":"Lee","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pupt.2015.07.003_bib88","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/bc040244z","article-title":"Neutral postgrafted colloidal particles for gene delivery","volume":"16","author":"Thompson","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.pupt.2015.07.003_bib89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1517\/17425247.3.5.563","article-title":"pH-responsive shielding of non-viral gene vectors","volume":"3","author":"Meyer","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.pupt.2015.07.003_bib90","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.gt.3301663","article-title":"Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus","volume":"9","author":"Sanders","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib91","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.taap.2009.10.001","article-title":"PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships","volume":"242","author":"Beyerle","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pupt.2015.07.003_bib92","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/10611860903106414","article-title":"Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery","volume":"17","author":"Kleemann","year":"2009","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.pupt.2015.07.003_bib93","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-4165(02)00334-3","article-title":"Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine","volume":"1573","author":"Rudolph","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pupt.2015.07.003_bib94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-3659(02)00355-3","article-title":"Mobility and stability of gene complexes in biogels","volume":"87","author":"Sanders","year":"2003","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib95","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/jgm.1255","article-title":"Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs","volume":"10","author":"Nguyen","year":"2008","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib96","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4155\/tde.11.73","article-title":"Screening of siRNA nanoparticles for delivery to airway epithelial cells using high-content analysis","volume":"2","author":"Hibbitts","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.pupt.2015.07.003_bib97","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/mt.2012.20","article-title":"PEGylated polyplex with optimized PEG shielding enhances gene introduction in lungs by minimizing inflammatory responses","volume":"20","author":"Uchida","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib98","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.pupt.2015.07.003_bib99","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"30","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.pupt.2015.07.003_bib100","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pupt.2015.07.003_bib101","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1021\/bc025529v","article-title":"Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system","volume":"13","author":"Petersen","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.pupt.2015.07.003_bib102","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/anie.201208556","article-title":"Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers","volume":"52","author":"Kim","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.pupt.2015.07.003_bib103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2014.01.007","article-title":"Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier","volume":"178C","author":"Suk","year":"2014","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib104","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1183\/09031936.96.09030531","article-title":"The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis","volume":"9","author":"Shah","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2015.07.003_bib105","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1164\/ajrccm.162.5.9909009","article-title":"Cystic fibrosis sputum: a barrier to the transport of nanospheres","volume":"162","author":"Sanders","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib106","doi-asserted-by":"crossref","first-page":"L1319","DOI":"10.1152\/ajplung.00329.2003","article-title":"Regulation of LPS-mediated inflammation in\u00a0vivo and in\u00a0vitro by the thiol antioxidant Nacystelyn","volume":"286","author":"Antonicelli","year":"2004","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.pupt.2015.07.003_bib107","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.TP.0000043924.09647.61","article-title":"Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory t cells","volume":"75","author":"Vosters","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.pupt.2015.07.003_bib108","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.gt.3300840","article-title":"The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium","volume":"6","author":"Kitson","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib109","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/sj.gt.3301525","article-title":"Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium","volume":"8","author":"Ferrari","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1015139527747","article-title":"On the transport of lipoplexes through cystic fibrosis sputum","volume":"19","author":"Sanders","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pupt.2015.07.003_bib111","doi-asserted-by":"crossref","first-page":"50393","DOI":"10.1074\/jbc.M309026200","article-title":"Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport","volume":"278","author":"Dawson","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.pupt.2015.07.003_bib112","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.pupt.2006.08.008","article-title":"Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics","volume":"20","author":"Broughton-Head","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib113","doi-asserted-by":"crossref","first-page":"e19919","DOI":"10.1371\/journal.pone.0019919","article-title":"Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients","volume":"6","author":"Hida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2015.07.003_bib114","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/mt.2011.160","article-title":"N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles","volume":"19","author":"Suk","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2213-0802-2-3","article-title":"The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update","volume":"2","author":"Laube","year":"2014","journal-title":"Transl. Respir. Med."},{"key":"10.1016\/j.pupt.2015.07.003_bib116","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11882-011-0177-8","article-title":"Gene therapy for allergic airway diseases","volume":"11","author":"Maes","year":"2011","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.pupt.2015.07.003_bib117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-0556-1-3","article-title":"Chitosan IFN-gamma-pDNA nanoparticle (CIN) therapy for allergic asthma","volume":"1","author":"Kumar","year":"2003","journal-title":"Genet. Vaccines Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib118","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1710-1492-4-3-95","article-title":"Chitosan interferon-gamma nanogene therapy for lung disease: modulation of T-cell and dendritic cell immune responses","volume":"4","author":"Kong","year":"2008","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.pupt.2015.07.003_bib119","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2249.2001.01493.x","article-title":"FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice","volume":"124","author":"Yara","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.pupt.2015.07.003_bib121","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/en.2008-0018","article-title":"Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway","volume":"149","author":"Henriques-Coelho","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.pupt.2015.07.003_bib122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2014.02.010","article-title":"DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma","volume":"180","author":"da Silva","year":"2014","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib123","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2015.986454","article-title":"Aerosol gene delivery using viral vectors and cationic carriers for in\u00a0vivo lung cancer therapy","volume":"12","author":"Hong","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.pupt.2015.07.003_bib124","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2217\/fon.13.67","article-title":"Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer","volume":"9","author":"Zarogoulidis","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.pupt.2015.07.003_bib125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1248\/bpb.13-00744","article-title":"Systemic delivery of small RNA using lipid nanoparticles","volume":"37","author":"Asai","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.pupt.2015.07.003_bib126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.2993","article-title":"Silencing disease genes in the laboratory and the clinic","volume":"226","author":"Watts","year":"2012","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.pupt.2015.07.003_bib127","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1681.2006.04403.x","article-title":"Antisense oligonucleotides: from design to therapeutic application","volume":"33","author":"Chan","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.pupt.2015.07.003_bib128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2012.12.015","article-title":"Efficient down-regulation of PKC-alpha gene expression in A549 lung cancer cells mediated by antisense oligodeoxynucleotides in dendrosomes","volume":"441","author":"Movassaghian","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2015.07.003_bib129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/ph6020223","article-title":"RNAi therapeutic platforms for lung diseases","volume":"6","author":"Fujita","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pupt.2015.07.003_bib130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2217\/nnm.14.214","article-title":"Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy","volume":"10","author":"Kim","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.pupt.2015.07.003_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2011.02.006","article-title":"Pulmonary delivery of therapeutic siRNA","volume":"64","author":"Lam","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib132","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/mt.2013.10","article-title":"Enhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexes","volume":"21","author":"Shim","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib133","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4161\/cbt.4.3.1496","article-title":"Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells","volume":"4","author":"Song","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib134","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s12032-011-0085-8","article-title":"MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance","volume":"29","author":"Luo","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.pupt.2015.07.003_bib135","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/mt.2013.291","article-title":"Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC","volume":"22","author":"Fehring","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib136","doi-asserted-by":"crossref","first-page":"18616","DOI":"10.1073\/pnas.1004654107","article-title":"Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression","volume":"107","author":"DeLisser","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pupt.2015.07.003_bib137","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.18632\/oncotarget.2664","article-title":"Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer","volume":"6","author":"McCarroll","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pupt.2015.07.003_bib138","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.biomaterials.2012.12.042","article-title":"Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA\/siRNA complex nanoparticles","volume":"34","author":"Yu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.pupt.2015.07.003_bib139","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/mt.2013.120","article-title":"Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC","volume":"21","author":"Zhang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2013.01.033","article-title":"Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells","volume":"167","author":"Andries","year":"2013","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib141","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejpb.2008.09.016","article-title":"Current prospects for mRNA gene delivery","volume":"71","author":"Yamamoto","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.pupt.2015.07.003_bib142","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1165\/rcmb.2006-0227TR","article-title":"Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function?","volume":"36","author":"Mattes","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pupt.2015.07.003_bib143","doi-asserted-by":"crossref","first-page":"756975","DOI":"10.1155\/2014\/756975","article-title":"Therapeutic use of microRNAs in lung cancer","volume":"2014","author":"Fortunato","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pupt.2015.07.003_bib144","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1002\/anie.201208077","article-title":"Systemic delivery of microRNA-34a for cancer stem cell therapy","volume":"52","author":"Shi","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.pupt.2015.07.003_bib145","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/mtna.2013.14","article-title":"Therapeutic delivery of microRNA-29b by cationic lipoplexes for lung cancer","volume":"2","author":"Wu","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.pupt.2015.07.003_bib146","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/mt.2014.79","article-title":"Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer","volume":"22","author":"Cortez","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib147","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2014.09.005","article-title":"Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression","volume":"194","author":"Shi","year":"2014","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib148","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1389450111314020002","article-title":"Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions","volume":"14","author":"Tzortzaki","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.pupt.2015.07.003_bib149","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/15412555.2013.764978","article-title":"Gene-based therapy for alpha-1 antitrypsin deficiency","volume":"10","author":"Mueller","year":"2013","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2015.07.003_bib150","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/10430340050015338","article-title":"Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy","volume":"11","author":"Brigham","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.pupt.2015.07.003_bib151","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/15412555.2013.764402","article-title":"Alpha-1 antitrypsin augmentation therapy","volume":"10","author":"Wewers","year":"2013","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2015.07.003_bib152","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2014.05.008","article-title":"Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies","volume":"75","author":"d'Angelo","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib153","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/gt.2011.55","article-title":"Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung","volume":"18","author":"McLachlan","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib154","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(98)06532-5","article-title":"Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial","volume":"353","author":"Alton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2015.07.003_bib155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt1399","article-title":"CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression","volume":"26","author":"Hyde","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pupt.2015.07.003_bib156","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/humc.2014.019","article-title":"Aerosol delivery of DNA\/liposomes to the lung for cystic fibrosis gene therapy","volume":"25","author":"Davies","year":"2014","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.pupt.2015.07.003_bib157","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/thoraxjnl-2012-202538","article-title":"Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation","volume":"68","author":"Horsley","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2015.07.003_bib158","doi-asserted-by":"crossref","first-page":"10828","DOI":"10.3390\/ijms130910828","article-title":"Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology","volume":"13","author":"Zarogouldis","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pupt.2015.07.003_bib159","first-page":"18","article-title":"Nanomedicine for respiratory diseases","volume":"11","author":"Bahadori","year":"2012","journal-title":"Tanaffos"},{"key":"10.1016\/j.pupt.2015.07.003_bib160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-59745-237-3_19","article-title":"Nanoparticle-mediated gene delivery to the lung","volume":"433","author":"Ramesh","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pupt.2015.07.003_bib161","doi-asserted-by":"crossref","first-page":"e34833","DOI":"10.1371\/journal.pone.0034833","article-title":"Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2015.07.003_bib162","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.onc.1202349","article-title":"Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma","volume":"18","author":"Wistuba","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.pupt.2015.07.003_bib163","doi-asserted-by":"crossref","first-page":"002","DOI":"10.4172\/2157-7412.S5-002","article-title":"Optimization of non-viral gene therapeutics using bilamellar invaginated vesicles","volume":"S5","author":"Templeton","year":"2011","journal-title":"J.\u00a0Genet. Syndr. Gene Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib164","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2014.06.055","article-title":"Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors","volume":"192","author":"Nafee","year":"2014","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.pupt.2015.07.003_bib165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0992-21","article-title":"Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis","volume":"2","author":"Johnson","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pupt.2015.07.003_bib166","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2013.49","article-title":"Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model","volume":"21","author":"Potash","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pupt.2015.07.003_bib167","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.05.001","article-title":"Lipid-based carriers for pulmonary products: preclinical development and case studies in humans","volume":"75","author":"Cipolla","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib168","first-page":"1","article-title":"Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages","author":"Lee","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.pupt.2015.07.003_bib169","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2014.05.014","article-title":"Carrier interactions with the biological barriers of the lung: advanced in\u00a0vitro models and challenges for pulmonary drug delivery","volume":"75","author":"de Souza Carvalho","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2015.07.003_bib170","unstructured":"http:\/\/clinicaltrials.gov. NCT01315678 and NCT01315236."}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915000760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915000760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T09:10:43Z","timestamp":1691831443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553915000760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":170,"alternative-id":["S1094553915000760"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2015.07.003","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}